SCHEMBL12038930

SCHEMBL12038930

O=C(O[n+]1c(F)c(F)c(F)c(F)c1F)N1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 5/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
GAA P10253 1/20 0.34
HSD11B1 P28845 1/20 0.34
TSHR P16473 1/20 0.34
LIPA P38571 3/20 0.33
HPGD P15428 3/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12038926 0.83 TP53 (0.42) POLBSMN1; SMN2KMT2AMEN1LMNA
SCHEMBL31718378 0.72 ALDH1A1 (0.55) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL12038841 0.69 HPGD (0.49) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL12038923 0.69 ALDH1A1 (0.47) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL20594175 0.65 L3MBTL1 (0.61) ALDH1A1SMN1; SMN2KMT2AMEN1HTT
SCHEMBL30443406 0.64 ALDH1A1 (0.54) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL30001850 0.63 HSD11B1 (0.47) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL12038832 0.63 ALDH1A1 (0.44) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL25352240 0.62 ALDH1A1 (0.52) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL28218130 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110318693-A1 ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2011-12-29 US disclosed
US-20110318691-A1 RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2011-12-29 US disclosed
US-20110318691-A1 RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110318691-A1 RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME RIF1, MSI2, SLIRP ALDH1A1 4155/4885POLB 512/4885SMN1; SMN2 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.